Electrophysiological effects of prucalopride, a novel enterokinetic agent, on isolated atrial myocytes from patients treated with β-adrenoceptor antagonists

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 1, 2005, Pages 146-153

  Pau, Davide ^a   Workman, Antony J ^a   Kane, Kathleen A ^b   Rankin, Andrew C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL L TYPE; PRUCALOPRIDE; SEROTONIN; SEROTONIN 4 AGONIST; SEROTONIN 4 RECEPTOR;

ACTION POTENTIAL; ADULT; ARTICLE; CALCIUM CURRENT; CLINICAL ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; GASTROINTESTINAL DISEASE; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART PROARRHYTHMIA; HEART REPOLARIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATCH CLAMP; PRIORITY JOURNAL;

ACTION POTENTIALS; ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; BENZOFURANS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; HEART ATRIA; HUMANS; INDOLES; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; SEROTONIN; SULFONAMIDES;

EID: 15744373380     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.076869     Document Type: Article

References (40)

1. 4b receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle. Naunyn Schmiedeberg's Arch Pharmacol 363:146-160.
2. + channels in human atrium. Basic Res Cardiol 97:424-433.
3. 4 receptor cloned from human atrium. FEBS Lett 412:465-474.
4. 4i. Naunyn-Schmiedeberg's Arch Pharmacol 369:616-628.
5. Briejer MR, Bosmans JP, Van Daele P, Jurzak M, Heylen L, Leysen JE, Prins NH, and Schuurkes JA (2001) The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound. Eur J Pharmacol 423:71-83.
6. Coremans G, Kerstens R, De Pauw M, and Stevens M (2003) Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief: results of a double-blind, placebo-controlled clinical trial. Digestion 67:82-89.
7. 4 receptor agonist, prucalopride, on colonic motility in healthy volunteers. Aliment Pharmacol Ther 16:603-612.
8. 4 receptors. Trends Pharmacol Sci 16:391-398.
9. Emmanuel AV, Roy AJ, Nicholls TJ, and Kamm MA (2002) Prucalopride, a systemic enterokinetic, for the treatment of constipation. Aliment Pharmacol Ther 16:1347-1356.
10. 2+-channel, β-adrenoreceptor and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation. Basic Res Cardiol 96:82-90.
11. 4 receptors. FASEB J 10:1398-1407.
12. 4 receptors by GR 113808. Br J Pharmacol 110:1172-1174.
13. 4 receptors mediate arrhythmias? Trends Pharmacol Sci 15:451-455.
14. 4 receptors in human atrium: facilitation by chronic β-adrenoceptor blockade. Naunyn-Schmiedeberg's Arch Pharmacol 349:331-337.
15. Kaumann AJ, Sanders L, Brown AM, Murray KJ, and Brown MJ (1990) A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 100:879-885.
16. Krogh K, Jensen MB, Gandrup P, Laurberg S, Nilsson J, Kerstens R, and De Pauw M (2002) Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury. Scand J Gastroenterol 37:431-436.
17. 4 receptor ligands: applications and new prospects. J Med Chem 46:319-344.
18. + current through a nifedipine inhibited inward channel. J Pharmacol Exp Ther 286:9-22.
19. 4 receptor and the amyloid precursor protein processing. Exp Gerontol 38:159-166.
20. + current in human ventricular myocytes. Circ Res 78:689-696.
21. 4 receptor in the central nervous system by TaqMan real time RT-PCR. Brain Res Mol Brain Res 90:125-134.
22. 4 receptors. Mol Pharmacol 41:346-351.
23. Pau D, Workman AJ, Kane KA, and Rankin AC (2003) Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes and the influence of chronic β-adrenoceptor blockade. Br J Pharmacol 140:1434-1441.
24. αi/o-proteins. Mol Pharmacol 61:85-96.
25. + channel. J Pharmacol Exp Ther 299:1007-1012.
26. 4 receptors in the human isolated large intestinal circular muscle. Br J Pharmacol 129:1601-1608.
27. 4 receptor antagonist RS-100302 in experimental atrial flutter and fibrillation. Circulation 100:2010-2017.
28. 4 receptor regulates secretion of non-amyloidogenic precursor protein. J Biol Chem 276:44881-44888.
29. 4 receptors by chronic β-blocker treatment. Circulation 92:2526-2539.
30. Talley NJ (1992) Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther 6:273-289.
31. Talley NJ (2001) Serotoninergic neuroenteric modulators. Lancet 358:2061-2068.
32. Tonini M, De Ponti F, Di Nucci A, and Crema F (1999) Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 13:1585-1591.
33. 4 receptor variants. Neuropharmacology 42:60-73.
34. Viskin S (1999) Long QT syndromes and torsade de pointes. Lancet 354:1625-1633.
35. Wang Z, Fermini B, and Nattel S (1994) Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res 28:1540-1546.
36. 4 receptors in brain tissues from patients with neurodegenerative disorders. Behav Brain Res 73:249-252.
37. Workman AJ, Kane KA, and Rankin AC (2001) The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res 52:226-235.
38. World Medical Association (1997) World Medical Association Declaration of Helsinki: recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 35:2-3.
39. Yue L, Feng J, Li GR, and Nattel S (1996) Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods. Am J Physiol 270:H2157-H2168.
40. Yusuf S, Al Saady N, and Camm AJ (2003) 5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle? J Cardiovasc Electrophysiol 14:209-214.